Year-end Sale % OFF 
Abstract
BackgroundPseudouridine synthase (PUS) 7 is a member of the PUS family that catalyses pseudouridine formation. It has been shown to be involved in intellectual development and haematological malignancies. Nevertheless, the role and the underlying molecular mechanisms of PUS7 in solid tumours, such as colorectal cancer (CRC), remain unexplored. This study elucidated, for the first time, the role of PUS7 in CRC cell metastasis and the underlying mechanisms.MethodsWe conducted immunohistochemistry, qPCR, and western blotting to quantify the expression of PUS7 in CRC tissues as well as cell lines. Besides, diverse in vivo and in vitro functional tests were employed to establish the function of PUS7 in CRC. RNA-seq and proteome profiling analysis were also applied to identify the targets of PUS7. PUS7-interacting proteins were further uncovered using immunoprecipitation and mass spectrometry.ResultsOverexpression of PUS7 was observed in CRC tissues and was linked to advanced clinical stages and shorter overall survival. PUS7 silencing effectively repressed CRC cell metastasis, while its upregulation promoted metastasis, independently of the PUS7 catalytic activity. LASP1 was identified as a downstream effector of PUS7. Forced LASP1 expression abolished the metastasis suppression triggered by PUS7 silencing. Furthermore, HSP90 was identified as a client protein of PUS7, associated with the increased PUS7 abundance in CRC. NMS-E973, a specific HSP90 inhibitor, also showed higher anti-metastatic activity when combined with PUS7 repression. Importantly, in line with these results, in human CRC tissues, the expression of PUS7 was positively linked to the expression of HSP90 and LASP1, and patients co-expressing HSP90/PUS7/LASP1 showed a worse prognosis.ConclusionsThe HSP90-dependent PUS7 upregulation promotes CRC cell metastasis via the regulation of LASP1. Thus, targeting the HSP90/PUS7/LASP1 axis may be a novel approach for the treatment of CRC.
Highlights
Pseudouridine synthase (PUS) 7 is a member of the Pseudouridine synthases (PUSs) family that catalyses pseudouridine formation
Pseudouridine synthase 7 (PUS7) was strongly stained in colorectal cancer (CRC) tissues; its expression was more commonly observed in CRC tissues than in other cancer subtypes (Fig. 1a)
We explored the median expression of PUS7 mRNA across all tumour samples and matched nonmalignant tissues using the Gene Expression Profiling Interactive Analysis (GEPIA) [47] website
Summary
Pseudouridine synthase (PUS) 7 is a member of the PUS family that catalyses pseudouridine formation. The role and the underlying molecular mechanisms of PUS7 in solid tumours, such as colorectal cancer (CRC), remain unexplored. Metastasis constitutes the major factor contributing to the high relapse rate and poor survival among individuals with CRC [2,3,4]. Despite advancements in both diagnosis and systemic treatment, patients with advanced distal organ metastasis still exhibit a poor prognosis [3]. The molecular mechanisms underlying CRC metastasis are still unclear, and advanced metastatic CRC remains incurable [3, 5].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Experimental & Clinical Cancer Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
